232 related articles for article (PubMed ID: 25002506)
1. Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3.
Galan JA; Geraghty KM; Lavoie G; Kanshin E; Tcherkezian J; Calabrese V; Jeschke GR; Turk BE; Ballif BA; Blenis J; Thibault P; Roux PP
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):E2918-27. PubMed ID: 25002506
[TBL] [Abstract][Full Text] [Related]
2. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.
Cuesta R; Holz MK
Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.
Méant A; Gao B; Lavoie G; Nourreddine S; Jung F; Aubert L; Tcherkezian J; Gingras AC; Roux PP
Mol Cell Proteomics; 2020 Jan; 19(1):50-64. PubMed ID: 31678930
[TBL] [Abstract][Full Text] [Related]
4. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917
[TBL] [Abstract][Full Text] [Related]
5. p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling.
Abe Y; Yoon SO; Kubota K; Mendoza MC; Gygi SP; Blenis J
J Biol Chem; 2009 May; 284(22):14939-48. PubMed ID: 19332537
[TBL] [Abstract][Full Text] [Related]
6. Complex formation between S100B protein and the p90 ribosomal S6 kinase (RSK) in malignant melanoma is calcium-dependent and inhibits extracellular signal-regulated kinase (ERK)-mediated phosphorylation of RSK.
Hartman KG; Vitolo MI; Pierce AD; Fox JM; Shapiro P; Martin SS; Wilder PT; Weber DJ
J Biol Chem; 2014 May; 289(18):12886-95. PubMed ID: 24627490
[TBL] [Abstract][Full Text] [Related]
7. RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth.
Romeo Y; Moreau J; Zindy PJ; Saba-El-Leil M; Lavoie G; Dandachi F; Baptissart M; Borden KLB; Meloche S; Roux PP
Oncogene; 2013 Jun; 32(24):2917-2926. PubMed ID: 22797077
[TBL] [Abstract][Full Text] [Related]
8. RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance.
Ray-David H; Romeo Y; Lavoie G; Déléris P; Tcherkezian J; Galan JA; Roux PP
Oncogene; 2013 Sep; 32(38):4480-9. PubMed ID: 23108403
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.
Yang S; Ji M; Zhang L; Chen Y; Wennmann DO; Kremerskothen J; Dong J
Cell Signal; 2014 Feb; 26(2):343-51. PubMed ID: 24269383
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity.
Cavet ME; Lehoux S; Berk BC
J Biol Chem; 2003 May; 278(20):18376-83. PubMed ID: 12618428
[TBL] [Abstract][Full Text] [Related]
11. P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation.
Li P; Goto H; Kasahara K; Matsuyama M; Wang Z; Yatabe Y; Kiyono T; Inagaki M
Mol Biol Cell; 2012 Apr; 23(8):1582-92. PubMed ID: 22357623
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein bad.
Eisenmann KM; VanBrocklin MW; Staffend NA; Kitchen SM; Koo HM
Cancer Res; 2003 Dec; 63(23):8330-7. PubMed ID: 14678993
[TBL] [Abstract][Full Text] [Related]
13. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
[TBL] [Abstract][Full Text] [Related]
14. The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling.
Lopez J; Bonsor DA; Sale MJ; Urisman A; Mehalko JL; Cabanski-Dunning M; Castel P; Simanshu DK; McCormick F
J Biol Chem; 2023 Jun; 299(6):104789. PubMed ID: 37149146
[TBL] [Abstract][Full Text] [Related]
15. Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses.
Kroczynska B; Sharma B; Eklund EA; Fish EN; Platanias LC
Mol Cell Biol; 2012 Jul; 32(14):2809-22. PubMed ID: 22586265
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Roux PP; Richards SA; Blenis J
Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.
Kosnopfel C; Wendlinger S; Niessner H; Siewert J; Sinnberg T; Hofmann A; Wohlfarth J; Schrama D; Berthold M; Siedel C; Sauer B; Jayanthan A; Lenz G; Dunn SE; Schilling B; Schittek B
J Exp Clin Cancer Res; 2023 Jul; 42(1):175. PubMed ID: 37464364
[TBL] [Abstract][Full Text] [Related]
18. Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase,
Goel RK; Paczkowska M; Reimand J; Napper S; Lukong KE
Mol Cell Proteomics; 2018 May; 17(5):925-947. PubMed ID: 29496907
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization.
Fujita N; Sato S; Tsuruo T
J Biol Chem; 2003 Dec; 278(49):49254-60. PubMed ID: 14504289
[TBL] [Abstract][Full Text] [Related]
20. The RSK factors of activating the Ras/MAPK signaling cascade.
Carriere A; Ray H; Blenis J; Roux PP
Front Biosci; 2008 May; 13():4258-75. PubMed ID: 18508509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
